Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
Actual shortage: | 218 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2019-08-14 | 2019-10-15 | 91532 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2023-08-12 | 2023-11-17 | 201716 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8859 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-05-24 | 2024-07-05 | 228813 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-08-15 | 2024-10-04 | 235348 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-10-18 | 2024-11-29 | 240616 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-11-21 | 2025-01-03 | 243623 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-01-21 | 2022-03-17 | 153271 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-02-06 | 2025-05-02 | 249749 |
APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2025-03-27 | 2025-04-04 | 253499 |
APO-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-09 | 255205 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-22 | 2020-12-30 | 124783 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-28 | 2020-12-30 | 127339 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-01-22 | 2021-01-29 | 132349 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137238 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210674 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-04-21 | 2023-07-27 | 190011 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2024-01-19 | 2025-04-15 | 216646 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-11-04 | 2023-02-09 | 173826 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |